Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2011-08-30
2011-08-30
Prouty, Rebecca (Department: 1653)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C423S594800
Reexamination Certificate
active
08008035
ABSTRACT:
The present invention is directed to a composition comprising a vanadium-containing phosphatase inhibitor and a polyol. In the presence of the polyol the effect of the inhibitor is enhanced, even in the presence of chelating agents or reducing agents. The invention also concerns the use of the inventive composition for inhibiting a phosphatase, as well as kits comprising the composition.
REFERENCES:
patent: 4976921 (1990-12-01), Itagaki et al.
patent: 5776714 (1998-07-01), Snoke
patent: 5858648 (1999-01-01), Steel et al.
patent: 6299865 (2001-10-01), Styczynski et al.
patent: 2006/0252683 (2006-11-01), Lim Tung
patent: 0051964 (1982-05-01), None
patent: 0524633 (1993-01-01), None
patent: 99/58097 (1999-11-01), None
patent: 00/57184 (2000-09-01), None
patent: 03/029209 (2003-04-01), None
patent: 2004/052412 (2004-06-01), None
patent: 2005/054257 (2004-06-01), None
Ko, Y.H. et al. Signal Transduction to Mitochondrial ATP Synthase: Evidence That PDGF-Dependent Phosphorylation of the Gamma-Subunit Occurs in Several Cell Lines, Involves Tyrosine, and is Modulated by Lysophosphatidic Acid; Mitochondrion, vol. 1 (2002) pp. 339-348.
Lochhead et al. 5-Aminoimidazole-4-Carboximide Riboside Mimics the Effects of Insulin on the Expression of the 2 Key Gluconeogenic Genes PEPCK and Glucose-6-Phosphatase; Diabetes, vol. 49 (2000) pp. 896-903.
Gil-Puig et al. PIT-1 is Expressed in Normal and Tumorous Human Breast and Regulates GH Secretion and Cell Proliferation; European Journal of Endocrinology, vol. 153 (2005) pp. 335-344.
Le Bail et al. Estrogenic and Antiproliferative Activities on MCF-7 Human Breast Cancer Cells by Flavanoids; Cancer Letters, vol. 130 (1998) pp. 209-216.
Fang et al. Phosphorylation and Inactivation of Glycogen Synthase Kinase 3 by Protein Kinase A; Proceedings of the National Academy of Science, vol. 97, No. 22 (2000) pp. 11960-11965.
Cuncic, C. et al., “Bis (N, N-dimethylhydroxamido) hydroxooxovanadate Inhibition of Portein Tyrosine Phosphatase Activity in Intact Cells,” Biochemical Pharmacology, (1999) 58: 1859-1867.
Huyer, G. et al., “Mechanism of Inhibition of Prtoein-tyrosine Phophatases by Vanadate and Pervanadate,” The Journal of Biological Chemistry, (1997) 272;2: 843-851.
Naz, R. et al., “An 18 kDa Acid Phosphatase from Chicken Heart Possesses Phosphotransferase Activity,” The Protein Journal, (Feb. 2006) 25;2; 135-146.
Nzumalo, F. et al., “Kinetics and molecular modelling studies of the inhibition of protein tyrosine phosphatases by N,N-dimethylhydroxylamine complexes of vanadium(V),” JBIC (1998) 3:534-542.
Stankiewicz, P. et al., “Inhibition of Phosphate-Metabolizing Enzymes by Oxovanadium(V) Complexes,” Met. Ions Biol. Syst (1993) 31: 287-324.
Fernholz Erhard
Mayr Dorothea
Martin Paul
Prouty Rebecca
Roche Diagnostics Operations Inc.
LandOfFree
Enhancement of vanadium-containing phosphatase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancement of vanadium-containing phosphatase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of vanadium-containing phosphatase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2665535